Skip to content
buyWeak cluster of 410b5-1 plan

Kenneth Krogulski bought $4,635 of CPIX

director at CUMBERLAND PHARMACEUTICALS INC. 1,035 shares at an average of $4.48, traded Apr 1, 2025, filed May 9, 2025.

Conviction score
23
Value
$4,635
1,035 shares
Holdings after
284,753
+0% from before
From 52-week low
+311%
low $0.82, close $3.38
From 52-week high
-36%
high $5.25, as of Apr 1, 2025

Score components

  • Role
    Director
    +15
  • Trade size
    $5k at market
    0
  • Relative to holdings
    Under 1% of holdings (0.4%)
    -5
  • Price context
    36% below the 52-week high
    +8
  • Cluster
    4 insiders buying within 14 days
    +15
  • Repeat buying
    2 buys in 90 days
    +5
  • Track record
    Too few past buys to judge (1 with prices)
    0
  • 10b5-1 plan
    Pre-scheduled under a 10b5-1 plan
    -15

What happened after comparable buys

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

CPIXOct 9, 2026 · close 7.03
Since filing May 9, 2025: +92.9%SPY +40.2% · excess +52.6%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001628280-25-024346, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 1, 2025POpen-market purchase
Common Stock10b5-1
+45$4.24$191283,763May 9, 2025
Apr 2, 2025POpen-market purchase
Common Stock10b5-1
+45$4.39$198283,808May 9, 2025
Apr 3, 2025POpen-market purchase
Common Stock10b5-1
+45$4.21$189283,853May 9, 2025
Apr 4, 2025POpen-market purchase
Common Stock10b5-1
+45$4.23$190283,898May 9, 2025
Apr 7, 2025POpen-market purchase
Common Stock10b5-1
+45$4.19$189283,943May 9, 2025
Apr 8, 2025POpen-market purchase
Common Stock10b5-1
+45$4.14$186283,988May 9, 2025
Apr 9, 2025POpen-market purchase
Common Stock10b5-1
+45$4.09$184284,033May 9, 2025
Apr 10, 2025POpen-market purchase
Common Stock10b5-1
+45$4.01$180284,078May 9, 2025
Apr 11, 2025POpen-market purchase
Common Stock10b5-1
+45$4.02$181284,123May 9, 2025
Apr 14, 2025POpen-market purchase
Common Stock10b5-1
+55$4.03$222284,178May 9, 2025
Apr 15, 2025POpen-market purchase
Common Stock10b5-1
+55$4.14$228284,233May 9, 2025
Apr 16, 2025POpen-market purchase
Common Stock10b5-1
+55$4.23$233284,288May 9, 2025
Apr 17, 2025POpen-market purchase
Common Stock10b5-1
+55$4.61$254284,343May 9, 2025
Apr 21, 2025POpen-market purchase
Common Stock10b5-1
+55$4.79$263284,398May 9, 2025
Apr 22, 2025POpen-market purchase
Common Stock10b5-1
+55$4.74$261284,453May 9, 2025
Apr 23, 2025POpen-market purchase
Common Stock10b5-1
+55$5.01$276284,508May 9, 2025
Apr 24, 2025POpen-market purchase
Common Stock10b5-1
+55$5.12$282284,563May 9, 2025
Apr 25, 2025POpen-market purchase
Common Stock10b5-1
+55$4.94$272284,618May 9, 2025
Apr 28, 2025POpen-market purchase
Common Stock10b5-1
+45$4.91$221284,663May 9, 2025
Apr 29, 2025POpen-market purchase
Common Stock10b5-1
+45$4.93$222284,708May 9, 2025
Apr 30, 2025POpen-market purchase
Common Stock10b5-1
+45$4.79$216284,753May 9, 2025

Related signals

Other insiders at CUMBERLAND PHARMACEUTICALS INC and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,516
1,372 shares
+0%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$862
262 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$862
262 shares
+1%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$398
121 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$5,872
1,712 shares
+1%
33Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
A J Kazimi
Chairman and CEO
$1,166
340 shares
+0%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$1,166
340 shares
+1%
23Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Caroline Young
director
$578
168 shares
+1%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
Kenneth Krogulski
director
$4,513
935 shares
+0%
19Weak
CPIXbuy 410b5-1
CUMBERLAND PHARMACEUTICALS INC
James Jones
director
$807
168 shares
+0%

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Kenneth Krogulski bought $4,635 of CPIX | InsiderTell